NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q1 2023. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,868 | -32.6% | 5,921 | -30.9% | 0.00% | – |
| Q2 2023 | $63,645 | +85.9% | 8,566 | +73.4% | 0.00% | – |
| Q1 2023 | $34,234 | +52.4% | 4,940 | +126.1% | 0.00% | – |
| Q4 2022 | $22,462 | -54.2% | 2,185 | -17.7% | 0.00% | – |
| Q3 2022 | $49,000 | -58.1% | 2,654 | +16.9% | 0.00% | – |
| Q2 2022 | $117,000 | -24.0% | 2,270 | +9.0% | 0.00% | – |
| Q1 2022 | $154,000 | -27.0% | 2,083 | +41.8% | 0.00% | – |
| Q4 2021 | $211,000 | -49.6% | 1,469 | -27.5% | 0.00% | -100.0% |
| Q3 2021 | $419,000 | -6.7% | 2,025 | -4.4% | 0.00% | 0.0% |
| Q2 2021 | $449,000 | -48.9% | 2,118 | -56.3% | 0.00% | -50.0% |
| Q1 2021 | $879,000 | +17.5% | 4,848 | -27.7% | 0.00% | 0.0% |
| Q4 2020 | $748,000 | +21.6% | 6,706 | +18.2% | 0.00% | +100.0% |
| Q3 2020 | $615,000 | +101.6% | 5,674 | +55.2% | 0.00% | 0.0% |
| Q2 2020 | $305,000 | +6000.0% | 3,657 | +814.2% | 0.00% | – |
| Q1 2020 | $5,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |